Adenoviral eye infection can manifest itself in many forms ranging from conjunctivitis that is often self-limiting to keratitis, which can be prolonged.

To compare the clinical outcome with different treatment regimens in Acute Adenoviral Keratoconjunctivitis (AAK). The records of 110 patients diagnosed as AAK in two tertiary eye care centers were ...

The global fungal keratitis treatment market size to grow to USD 1323 million in 2030 at a CAGR of 6% from the early market figures of USD 777 million in 2021. North America has a dominance in the ...

Visual outcomes of children with herpes simplex keratitis were better when patients were seen within 5 days of symptom onset, according to a poster presentation.In a retrospective chart review of ...

Please provide your email address to receive an email when new articles are posted on . Comprehensive ophthalmologists and cornea specialists alike should rejoice at the recent approval of Sirion ...

1 Moorfields Eye Hospital, 162 City Rd, London EC1V 2PD, UK 1 Moorfields Eye Hospital, 162 City Rd, London EC1V 2PD, UK Corneal laser refractive surgery is an increasingly common form of optical ...

Researchers from the University of Liverpool’s Centre for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, ...

Compared with patients being treated with 3% acyclovir ophthalmic ointment for herpetic keratitis, patients receiving 0.15% ganciclovir ophthalmic gel had fewer relapses and tolerated the drug better.

The neurotrophic keratitis treatment market will expand from $1.07 billion in 2024 to $22.6 billion in 2034, fueled by rising aging populations, healthcare expenditure, and eye diseases. Western ...

TILT Biotherapeutics and MSD to Collaborate on Clinical Trial of Adenoviral Cancer Immunotherapeutic TILT-123 in Combination with KEYTRUDA ® (pembrolizumab) for Ovarian Cancer April 14, 2021 02: ...

Phase 2/3, randomized, open-label study of an individualized neoantigen vaccine (self-amplifying mRNA and adenoviral vectors) plus immune checkpoint blockade as maintenance for patients with newly ...